Smart quitting: new inhaler and heating technologies may aid smoking cessation

While there’s a diverse arsenal of nicotine replacement therapy (NRT) products on the market, their effectiveness for smoking cessation remains disappointing. However, a new wave of inhaler technology could finally deliver the swift relief smokers need to quit for good.

The wide array of nicotine replacement therapy products available includes lozenges, gums, nasal sprays and prescription inhalers, but their success rate in helping smokers permanently quit combustible cigarettes is underwhelming. According to a 2006 meta study by the Swiss Institute of Social and Preventive Medicine, the effectiveness of long-term smoking cessation with the help of NRTs stood at 7%. Several successive surveys have since confirmed that NRTs demonstrate limited success in meeting their actual goal.

Author default picture

TobaccoIntelligence

This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation